Tipepidine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses tipepidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Tipepidine Hibenzate
- 3
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Chiba University (3)
Studies
Open first, then newest update. How each study uses tipepidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled TrialCompletedPhase 1/2Chiba UniversityNCT02305134Written as Tipepidine Hibenzate
- An Open Study of Tipepidine Hibenzate in Adolescent Patients With DepressionCompletedPhase 2Chiba UniversityNCT01835847Written as Tipepidine Hibenzate
- An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)CompletedPhase 2Chiba UniversityNCT01835093Written as Tipepidine Hibenzate
Codes
What other systems call tipepidine · ClinicalTrials.gg INT002873
- MeSH (NLM) C028458tipepidineOne source NLM
- UNII (FDA) 2260ZP67ITTIPEPIDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q7808816tipepidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76847TipepidineOne source FDA
- DrugBank DB13474One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C028458 | tipepidine | One source NLM |
| UNII (FDA) | 2260ZP67IT | TIPEPIDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7808816 | tipepidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76847 | Tipepidine | One source FDA |
| DrugBank | DB13474 | — | One source Wikidata |
Also registered as tipepidine hibenzate (UNII 78578GFU8W).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.